Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nova Mentis Life Science Corp C.NOVA

Alternate Symbol(s):  NMLSF

Healthcare Biotechnology
Nova Mentis Life Science Corp. is a Canadian biotechnology company. The Company is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. The Company has orphan drug designation in both the United States and European Union for the use of psilocybin in the treatment of fragile X syndrome (FXS). Its focus is to diagnose and treat debilitating chronic... see more

Recent & Breaking News (CSE:NOVA)

Psilocybin is Being Studied to Help Treat Autism Spectrum Disorder

Livemoney January 13, 2021

Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board

Canada NewsWire January 13, 2021

Nova Mentis Appoints Dr. Kyle Ambert to Scientific Advisory Board

Canada NewsWire January 4, 2021

This is Why 2021 Could be Another Big Year for Psychedelics

Livemoney January 4, 2021

Nova Mentis Expands Psychedelic Drug Pipeline

Canada NewsWire December 29, 2020

This is Why Psychedelics Could Be One of The Top Opportunities of 2021

Livemoney December 29, 2020

IIROC Trade Resumption - NOVA

Canada NewsWire December 8, 2020

Nova Mentis Uncovers Diagnostic Biomarkers in Preclinical Autism Study

Canada NewsWire December 8, 2020

IIROC Trading Halt - NOVA

Canada NewsWire December 7, 2020

Nova Mentis Appoints Dr. Marvin S. Hausman as Chairman of Scientific Advisory Board

Canada NewsWire December 3, 2020

/R E P E A T -- Nova Mentis Life Science Completes Acquisition of Pilz Bioscience/

Canada NewsWire December 1, 2020

Nova Mentis Life Science Completes Acquisition of Pilz Bioscience

Canada NewsWire November 30, 2020

Nova Mentis Life Science Announces Receipt of Pilz Shareholder Approval

Canada NewsWire November 18, 2020

Pilz BioScience Senior Team Members To Participate In Upcoming Microdose Conference

Canada NewsWire November 17, 2020

Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Provides Corporate Update

Canada NewsWire November 11, 2020

Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement

Canada NewsWire November 5, 2020

Nova Mentis Life Science Signs Amalgamation Agreement to Acquire 100% of Pilz BioScience Corp.

Canada NewsWire November 2, 2020

/R E P E A T -- Nova Mentis Life Science Signs Agreement to Acquire 100% of Psychedelic-Focused Autism Research Company Pilz BioScience Corp./

Canada NewsWire October 13, 2020

Nova Mentis Life Science Signs Agreement to Acquire 100% of Psychedelic-Focused Autism Research Company Pilz BioScience Corp.

Canada NewsWire October 9, 2020

Former Senior Leader of Apotex Joins Nova Mentis Life Science Board and is Named COO

Canada NewsWire September 17, 2020